Drug correction of chronic cerebrovascular disorders

DOI: https://doi.org/10.29296/25877305-2021-09-11
Download full text PDF
Issue: 
9
Year: 
2021

Associate Professor I. Dolgova, MD; M. Khybyrtova Stavropol State Medical University

The paper presents the results of a study of akatinol memantine incorporated into basic antihypertensive and antiplatelet therapy for patients (n = 47) with Stages I and II chronic cerebral ischemia. The dynamics of clinical manifestations of cerebrovascular disorders was studied at 6 months and 1 year. Neuroimaging methods, neurophysiological and neuropsychological tests were used to objectify the results. Reversal of clinical manifestations was noted at both 6 months and 1 year of treatment. The most persistent result was found in the longer-term use of akatinol memantine.
Keywords: 
neurology
therapy
chronic brain ischemia
drug correction
akatinol memantine

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Levin O.S. Distsirkuljatornaja entsefalopatija: sovremennye predstavlenija o mehanizmah razvitija i lechenii. Consilium medicum. 2007; 8: 47–52 [Levin O.S. Distsirkulyatornaya entsefalopatiya: sovremennye predstavleniya o mekhanizmakh razvitiya i lechenii. Consilium medicum. 2007; 8: 47–52 (in Russ.)].
  2. Dolgova I.N. Hronicheskaja tserebrovaskuljarnaja patologija, obuslovlennaja arterial'noj gipo- i gipertenziej v molodom vozraste. Avtoref. diss. … d-ra med. nauk. Pjatigorsk, 2012; 43 s. [Dolgova I.N. Khronicheskaya tserebrovaskulyarnaya patologiya, obuslovlennaya arterial’noi gipo- i gipertenziei v molodom vozraste. Avtoref. diss. … d-ra med. nauk. Pyatigorsk, 2012; 43 s. (in Russ.)].
  3. Kadykov A.S. Reabilitatsija nevrologicheskih bol'nyh. M.: MEDpress-inform, 2008; 560 s. [Kadykov A.S. Reabilitatsiya nevrologicheskikh bol’nykh. M.: MEDpress-inform, 2008; 560 s. (in Russ.)].
  4. Sturov N. V. Sosudistaja entsefalopatija pri arterial'noj gipertenzii kak sochetanie kognitivnyh narushenij i organicheskogo porazhenija golovnogo mozga. Trudnyj patsient. 2011; 1: 3–6 [Sturov N. V. Sosudistaya entsefalopatiya pri arterial’noi gipertenzii kak sochetanie kognitivnykh narushenii i organicheskogo porazheniya golovnogo mozga. Trudnyi patsient. 2011; 1: 3–6 (in Russ.)].
  5. Dolgova I.N., Starodubtsev A.I. Kliniko-nevrologicheskie projavlenija hronicheskih tserebrovaskuljarnyh zabolevanij, obuslovlennyh arterial'noj gipertenziej. Kubanskij nauchnyj med vestnik. 2009; 7: 44–7 [Dolgova I.N., Starodubcev A.I. Clinico-neurological manifestation of the chronic cerebrovascular diseases caused by arterial hypertention. Kubanskii nauchnyi med vestnik. 2009; 7: 44–7 (in Russ.)].
  6. Dolgova I.N., Starodubtsev A.I. Hronicheskaja tserebrovaskuljarnaja patologija u patsientov molodogo vozrasta. Meditsinskij vestnik Severnogo Kavkaza. 2011; 1: 26–9 [Dolgova I.N., Starodubtsev A.I. The chronic cerebrovascular pathology in young patients. Meditsinskii vestnik Severnogo Kavkaza. 2011; 1: 26–9 (in Russ.)].
  7. Skvortsova V. I. Gipertonicheskaja entsefalopatija. Aktual'nye voprosy boleznej serdtsa i sosudov. 2006; 1: 46–8 [Skvortsova V. I. Gipertonicheskaya entsefalopatiya. Aktual’nye voprosy boleznei serdtsa i sosudov. 2006; 1: 46–8 (in Russ.)].